Companies: 10,795·Total market cap: $144.5T
Incyte Corporation

Incyte Corporation

INCYNASDAQHealthcare● Active
$102.38
+$1.14(+1.13%)
Market Cap$20.5B
P/E Ratio
52W High$112.29
52W Low$66.74

Incyte Corporation (INCY) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

incy · stock forecast · 44 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 44 Wall Street analysts in the past 3 months

SellBuy

Buy

44 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
23
Hold
19
Sell
2
Strong Sell
0
Total: 44 · Buy rate: 52.3%

12-Month Price Target

High

$135

Consensus

$109

+6.0% upside

Low

$90.00

Median: $107 · Last Close: $102.38

The Incyte Corporation (INCY) analyst consensus is Buy, based on ratings from 44 Wall Street analysts over the past 3 months. The average 12-month INCY price target is $108.55, representing +6.0% upside from the current price of $102.38.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $109 (6.0%)

Consensus Target

$108.55

6.0% upside

High Target

$135

31.9%

Low Target

$90

-12.1%

Current Price

$102.38

as of today

Based on analyst price targets, the INCY stock price prediction for the next 12 months ranges from $90 to $135. The consensus INCY price forecast of $108.55 implies 6.0% upside from the current price of $102.38.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$102.420.04%

1-day model range: $102.04–$102.79. Peak: $102.79 (+0.04%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$126+23.0%
2028$145+41.3%
2029$159+55.0%
2030$169+64.8%
2031+71.6%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%
13Buy
1Neutral
0Sell
RSI (14)69.2Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · INCY · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$97.89BUY
MA 10$97.53BUY
MA 20$97.52BUY
MA 50$96.51BUY
MA 100$98.06BUY
MA 200$96.00BUY
Current $INCY · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$99.33BUY
EMA 10$98.18BUY
EMA 20$97.59BUY
EMA 50$97.17BUY
EMA 100$96.83BUY
EMA 200$93.26BUY
Current $INCY · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
HC Wainwright & Co.2026-05-21
Maintains
BuyBuy
HC Wainwright & Co.2026-05-04
Maintains
BuyBuy
Oppenheimer2026-04-29
Maintains
PerformPerform
Stifel2026-04-29
Maintains
BuyBuy
HC Wainwright & Co.2026-04-15
Maintains
BuyBuy
HC Wainwright & Co.2026-03-30
Maintains
BuyBuy
UBS2026-03-25
Maintains
NeutralNeutral
HC Wainwright & Co.2026-03-25
Maintains
BuyBuy
Jefferies2026-03-16
Downgrade ↓
BuyHold
HC Wainwright & Co.2026-03-09
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Incyte Corporation (INCY) stock. Of the recent 321 rating actions, 23 were upgrades and 32 were downgrades. 44 analysts currently cover INCY.

Analyst Recommendation Trends

Buy ratings22
Hold ratings101
Sell ratings00

INCY analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$5.6B

↓ 12.9% YoY

Revenue Next Year

$6.2B

↑ 9.9% YoY

EPS This Year

$7.53

EPS Next Year

$8.89

↑ 18.1% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast INCY EPS of $7.53 for the current fiscal year, based on estimates from 17 analysts. The INCY revenue forecast is $5.6B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The INCY stock forecast is supported by two independent data sources: analyst consensus ratings from 44 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus INCY price target is $108.55 (+6.0% upside), with an analyst consensus of Buy.

The INCY short-term stock prediction for tomorrow is $102.42 (+0.04%). The INCY stock price prediction for 2027 estimates an average of $126. The INCY stock prediction for 2030 projects a range of $162–$176.

Incyte Corporation trades on NASDAQ under the ticker INCY. The INCY stock outlook for 2027 is broadly positive, supported by a Buy consensus among 52% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

INCY forecast · 8 questions

According to 44 Wall Street analysts, the average 12-month INCY price target is $108.55, with a high forecast of $135.00 and a low of $90.00. The median price target is shown in the chart above when available. This implies +6.0% potential upside from the current price of $102.38.

INCY price targetWhat is INCY price targetINCY analyst price targetINCY 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.